🇺🇸 FDA
Pipeline program

GC1102

GC1102

Phase 1 mab completed

Quick answer

GC1102 for Hepatitis B is a Phase 1 program (mab) at Green Valley (Shanghai) Pharmaceuticals Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Green Valley (Shanghai) Pharmaceuticals Co.,
Indication
Hepatitis B
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials